Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries

Journal article


Publication Details

Author(s): Eder-Czembirek C, Moser D, Holawe S, Brodowicz T, Ries J, Sulzbacher I, Selzer E
Journal: Clinics
Publication year: 2019
Volume: 74
ISSN: 1807-5932
eISSN: 1980-5322


Abstract

OBJECTIVES: Osteosarcoma of the jaw (OSAJ) is fundamentally different in clinical practice from its peripheral counterparts. Studies are difficult to conduct due to low incidence rates. The primary aim of this study was to provide for the first time a comprehensive retrospective analysis of the treatment concepts and outcome data of OSAJ patients treated at the University Hospital Vienna and to compare these with two recently published studies on OSAJ. The clinical study was accompanied by a biomarker study investigating the prognostic relevance of melanoma-associated antigen-A (MAGE-A) in OSAJ specimens.


External institutions with authors

Medizinische Universität Wien


How to cite

APA:
Eder-Czembirek, C., Moser, D., Holawe, S., Brodowicz, T., Ries, J., Sulzbacher, I., & Selzer, E. (2019). Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries. Clinics, 74. https://dx.doi.org/10.6061/clinics/2019/e701

MLA:
Eder-Czembirek, Christina, et al. "Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries." Clinics 74 (2019).

BibTeX: 

Last updated on 2019-17-05 at 15:08